DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Terutroban
Terutroban
(12) United States Patent (10) Patent No.: US 9,498,481 B2 Rao Et Al
Prevention of Atherothrombotic Events in Patients with Diabetes Mellitus: from Antithrombotic Therapies to New-Generation Glucose-Lowering Drugs
Xử Trí Quá Liều Thuốc Chống Đông
Antithrombotic Treatment After Stroke Due to Intracerebral Haemorrhage (Review)
Inverse Agonism of SQ 29,548 and Ramatroban on Thromboxane A2 Receptor
Effect of Prostanoids on Human Platelet Function: an Overview
Modifications to the Harmonized Tariff Schedule of the United States To
Pharmaceutical Appendix to the Tariff Schedule 2
Advances in Interventional Cardiology New Directions In
Cardio Pharmacology
Terutroban Et Récepteurs TP Endothéliaux Dans L'athérogenèse
Renal Effects of S18886 (Terutroban), a TP Receptor Antagonist, in an Experimental Model of Type 2 Diabetes
Head Injury Partial Update
Novel Antiplatelet Drugs in Clinical Development
The Roles of Various Prostaglandins in Fibrosis: a Review
WO 2016/087994 Al 9 June 2016 (09.06.2016) P O P C T
Predicting Drug Responses by Propagating Interactions Through Text-Enhanced Drug-Gene Networks
Search Strategy Systematic Review of Effect of Statins and Antiplatelets On
Top View
Xét Nghiệm Đánh Giá Khi Dùng Thuốc Chống Đông Đường Uống Và Đường Tiêm
Customs Tariff - Schedule
Pharmaabkommen A1 E
Recent Progress and Market Analysis of Anticoagulant Drugs
Customs Tariff - Schedule Xxi - 1
Thromboxane–Prostaglandin Receptor Antagonist, Terutroban, Prevents
Prostaglandin Receptor
JPET #174821 1 Title Page Prostaglandin E2 Differentially
Terutroban Versus Aspirin in Patients with Cerebral Ischaemic Events (PERFORM): a Randomised, Double-Blind, Parallel-Group Trial
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
WHO Drug Information Vol 19, No
New Pharmacologic Therapy for Hypertension in Pregnancy Byrne TJ*
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Antiplatelet Therapy – a Pharmacologist’S Perspective
Terutroban, a Tpreceptor Antagonist, Reduces Portal Pressure in Cirrhotic Rats
(12) Patent Application Publication (10) Pub. No.: US 2013/0095095 A1 Lines (43) Pub
Thromboxane Receptors Antagonists And/Or Synthase Inhibitors
Jpet#165787 1 Terutroban, a Tp Receptor Antagonist, Increases Survival in Stroke-Prone Rats by Preventing Systemic Inflammation